61. Autoimmune hemolytic anemia Clinical trials / Disease details


Clinical trials : 137 Drugs : 127 - (DrugBank : 55) / Drug target genes : 26 - Drug target pathways : 153

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04661033
(ClinicalTrials.gov)
September 9, 20211/12/2020Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)A Multicenter, Open-label, Non-randomized, Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic AnemiaWarm Autoimmune Hemolytic Anemia (wAIHA)Drug: Isatuximab SAR650984SanofiNULLRecruiting18 YearsN/AAll23Phase 1/Phase 2United States;Belgium;France;Germany;Hungary;Italy;Netherlands;United Kingdom
2EUCTR2020-003880-24-NL
(EUCTR)
09/06/202103/02/2021Safety, pharmacokinetics, and efficacy of subcutaneous isatuximab in adults with warm autoimmune hemolytic anemiaA multicenter, open-label, non-randomized, Phase 1b/2 study to evaluate the safety, pharmacokinetics,and efficacy of subcutaneous isatuximab in adults with warm autoimmune hemolytic anemia Warm autoimmune hemolytic anemia
MedDRA version: 20.0;Level: PT;Classification code 10047822;Term: Warm type haemolytic anaemia;System Organ Class: 10005329 - Blood and lymphatic system disorders;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
Product Name: Isatuximab
Product Code: SAR650984
INN or Proposed INN: Isatuximab
Other descriptive name: SAR650984
Sanofi-Aventis Recherche & DeveloppementNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
23Phase 1;Phase 2France;United States;Hungary;Belgium;Germany;Netherlands;United Kingdom;Italy
3EUCTR2020-003880-24-DE
(EUCTR)
24/03/202114/12/2020Safety, pharmacokinetics, and efficacy of subcutaneous isatuximab in adults with warm autoimmunehemolytic anemiaA multicenter, open-label, non-randomized, Phase 1b/2 study to evaluate the safety, pharmacokinetics,and efficacy of subcutaneous isatuximab in adults with warm autoimmune hemolytic anemia Warm autoimmune hemolytic anemia
MedDRA version: 20.0;Level: PT;Classification code 10047822;Term: Warm type haemolytic anaemia;System Organ Class: 10005329 - Blood and lymphatic system disorders;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
Product Name: Isatuximab
Product Code: SAR650984
INN or Proposed INN: Isatuximab
Other descriptive name: SAR650984
Sanofi-Aventis Recherche & DeveloppementNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
23Phase 1;Phase 2France;United States;Hungary;Belgium;Netherlands;Germany;United Kingdom;Italy
4EUCTR2020-003880-24-HU
(EUCTR)
18/03/202128/01/2021Safety, pharmacokinetics, and efficacy of subcutaneous isatuximab in adults with warm autoimmunehemolytic anemiaA multicenter, open-label, non-randomized, Phase 1b/2 study to evaluate the safety, pharmacokinetics,and efficacy of subcutaneous isatuximab in adults with warm autoimmune hemolytic anemia Warm autoimmune hemolytic anemia
MedDRA version: 20.0;Level: PT;Classification code 10047822;Term: Warm type haemolytic anaemia;System Organ Class: 10005329 - Blood and lymphatic system disorders;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
Product Name: Isatuximab
Product Code: SAR650984
INN or Proposed INN: Isatuximab
Other descriptive name: SAR650984
Sanofi-Aventis Recherche & DeveloppementNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
23Phase 1;Phase 2France;United States;Hungary;Belgium;Netherlands;Germany;United Kingdom;Italy